Status:
UNKNOWN
Evaluation of Kinesophobia in Patients With Metabolic Syndrome
Lead Sponsor:
Erol Olcok Corum Training and Research Hospital
Conditions:
Kinesiophobia
Metabolic Syndrome
Eligibility:
All Genders
45-65 years
Brief Summary
Metabolic syndrome (MS) is a public health problem characterized by central obesity, increased blood pressure and triglyceride levels, decreased blood HDL levels and the presence of insulin resistance...
Eligibility Criteria
Inclusion
- Patients with metabolic syndrome
Exclusion
- Patients with rheumatic disease
- Patients with neurologic disease
- Patients with history of trauma
- Patients with gonartrosis
- Pateints with fibromialgia
Key Trial Info
Start Date :
September 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04123132
Start Date
September 25 2019
End Date
February 1 2020
Last Update
January 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dilek Eker Büyükşireci
Çorum, Central Anatolia, Turkey (Türkiye)